Debt-to-equity of Cardiff Oncology, Inc. from 30 Sep 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cardiff Oncology, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2012 to 30 Sep 2025.
  • Cardiff Oncology, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 23%, a 2.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Cardiff Oncology, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 23% +1% +2.8% 30 Sep 2025
Q2 2025 22% +4% +19% 30 Jun 2025
Q1 2025 22% +6% +37% 31 Mar 2025
Q4 2024 22% +9% +69% 31 Dec 2024
Q3 2024 22% +11% +99% 30 Sep 2024
Q2 2024 19% +9% +85% 30 Jun 2024
Q1 2024 16% +6% +68% 31 Mar 2024
Q4 2023 13% +5% +54% 31 Dec 2023
Q3 2023 11% +3% +44% 30 Sep 2023
Q2 2023 10% +3% +46% 30 Jun 2023
Q1 2023 9% +4% +66% 31 Mar 2023
Q4 2022 9% +4% +74% 31 Dec 2022
Q3 2022 8% +3% +72% 30 Sep 2022
Q2 2022 7% +2% +35% 30 Jun 2022
Q1 2022 6% -2% -23% 31 Mar 2022
Q4 2021 5% -8% -60% 31 Dec 2021
Q3 2021 5% -28% -86% 30 Sep 2021
Q2 2021 5% -45% -90% 30 Jun 2021
Q1 2021 7% -68% -90% 31 Mar 2021
Q4 2020 12% -52% -81% 31 Dec 2020
Q3 2020 32% -22% -41% 30 Sep 2020
Q2 2020 50% +8% +20% 30 Jun 2020
Q1 2020 75% +42% +124% 31 Mar 2020
Q4 2019 64% +25% +65% 31 Dec 2019
Q3 2019 54% +8% +18% 30 Sep 2019
Q2 2019 42% -32% -43% 30 Jun 2019
Q1 2019 34% -121% -78% 31 Mar 2019
Q4 2018 39% -149% -79% 31 Dec 2018
Q3 2018 46% -125% -73% 30 Sep 2018
Q2 2018 74% -62% -46% 30 Jun 2018
Q1 2018 155% +46% +42% 31 Mar 2018
Q4 2017 188% +105% +128% 31 Dec 2017
Q3 2017 171% +105% +160% 30 Sep 2017
Q2 2017 136% +83% +157% 30 Jun 2017
Q1 2017 109% +50% +86% 31 Mar 2017
Q4 2016 83% +19% +30% 31 Dec 2016
Q3 2016 66% -21% -24% 30 Sep 2016
Q2 2016 53% -89% -63% 30 Jun 2016
Q1 2016 59% -75% -56% 31 Mar 2016
Q4 2015 64% -55% -46% 31 Dec 2015
Q3 2015 86% +9% +11% 30 Sep 2015
Q2 2015 142% +90% +170% 30 Jun 2015
Q1 2015 133% +74% +125% 31 Mar 2015
Q4 2014 119% +32% +36% 31 Dec 2014
Q3 2014 78% -93% -55% 30 Sep 2014
Q2 2014 53% -493% -90% 30 Jun 2014
Q1 2014 59% -126% -68% 31 Mar 2014
Q4 2013 88% -190% -69% 31 Dec 2013
Q3 2013 171% -821% -83% 30 Sep 2013
Q2 2013 545% 30 Jun 2013
Q1 2013 185% 31 Mar 2013
Q4 2012 278% 31 Dec 2012
Q3 2012 992% 30 Sep 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.